| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Brittenham Marissa | Chief Strategy Officer | C/O SURGERY PARTNERS, INC., 340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD | /s/ Jennifer Baldock, Attorney-in-Fact | 16 Mar 2026 | 0001908044 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGRY | Common Stock | Sale | $45,859 | -3,657 | -3.7% | $12.54 | 94,196 | 13 Mar 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026. |